Suppr超能文献

人类胃肠道内的低缓冲容量和交替蠕动:对可离子化药物体内溶解和吸收的影响。

Low Buffer Capacity and Alternating Motility along the Human Gastrointestinal Tract: Implications for in Vivo Dissolution and Absorption of Ionizable Drugs.

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan , Ann Arbor, Michigan 48109, United States.

Department of Engineering, Pharmacy Section, Miguel Hernandez University , San Juan de Alicante, 03550 Alicante, Spain.

出版信息

Mol Pharm. 2017 Dec 4;14(12):4281-4294. doi: 10.1021/acs.molpharmaceut.7b00426. Epub 2017 Aug 4.

Abstract

In this study, we determined the pH and buffer capacity of human gastrointestinal (GI) fluids (aspirated from the stomach, duodenum, proximal jejunum, and mid/distal jejunum) as a function of time, from 37 healthy subjects after oral administration of an 800 mg immediate-release tablet of ibuprofen (reference listed drug; RLD) under typical prescribed bioequivalence (BE) study protocol conditions in both fasted and fed states (simulated by ingestion of a liquid meal). Simultaneously, motility was continuously monitored using water-perfused manometry. The time to appearance of phase III contractions (i.e., housekeeper wave) was monitored following administration of the ibuprofen tablet. Our results clearly demonstrated the dynamic change in pH as a function of time and, most significantly, the extremely low buffer capacity along the GI tract. The buffer capacity on average was 2.26 μmol/mL/ΔpH in fasted state (range: 0.26 and 6.32 μmol/mL/ΔpH) and 2.66 μmol/mL/ΔpH in fed state (range: 0.78 and 5.98 μmol/mL/ΔpH) throughout the entire upper GI tract (stomach, duodenum, and proximal and mid/distal jejunum). The implication of this very low buffer capacity of the human GI tract is profound for the oral delivery of both acidic and basic active pharmaceutical ingredients (APIs). An in vivo predictive dissolution method would require not only a bicarbonate buffer but also, more significantly, a low buffer capacity of dissolution media to reflect in vivo dissolution conditions.

摘要

在这项研究中,我们确定了人类胃肠道(GI)液体的 pH 值和缓冲能力(从空腹和进食状态下(通过摄入液体餐模拟),37 名健康受试者口服 800mg 布洛芬速释片后,从胃、十二指肠、近端空肠和中/远端空肠吸出)随时间的变化,这是典型的规定生物等效性(BE)研究方案条件下的函数。同时,使用水灌注测压法连续监测运动。在给予布洛芬片剂后,监测出现 III 相收缩(即管家波)的时间。我们的研究结果清楚地表明了 pH 值随时间的动态变化,最重要的是,胃肠道中极低的缓冲能力。在禁食状态下,缓冲能力平均为 2.26μmol/mL/ΔpH(范围:0.26-6.32μmol/mL/ΔpH),在进食状态下,缓冲能力平均为 2.66μmol/mL/ΔpH(范围:0.78-5.98μmol/mL/ΔpH),整个上胃肠道(胃、十二指肠和近端及中/远端空肠)均为如此。人类胃肠道极低的缓冲能力对酸性和碱性活性药物成分(APIs)的口服递送具有深远的意义。体内预测溶解方法不仅需要碳酸氢盐缓冲液,而且更重要的是需要具有低缓冲能力的溶解介质来反映体内溶解条件。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验